|
||||||||||||||||||||||||||||
| Protein Kinase Information : List of Protein Kinase | ||||||||||||||||||||||||||||
| # | NAME | Sp | aa ACC# | Name/Notes | Group | Family | aa | CHR location | Homology (AA:AA unless indicated) | |||||||||||||||||||
| 1 | AKT h | H | NP 005154 | RACa h (AKT) | AGC | AKT | 480 | 14q32.3 (OMIM) | ||||||||||||||||||||
| 2 | AKT2 h | H | AAA36585 | RACb h; PKBb; AKT2 | AGC | AKT | 520 | 19q13.1-13.2 (Factsbook) | ||||||||||||||||||||
| 3 | AKT3 h | H | NP 005456 | RACg h; AKT3 | AGC | AKT | 479 | NA | 43aa RAC g r 95% RACa h 85% | |||||||||||||||||||
| 4 | PDK1 h | H | NP 0026204 | PDK1, PKB | AGC | AKT | 556 | 16p13.3 (gene list) | 262aa PKACb h 39%; PKCa 38%; Racb h 39% | |||||||||||||||||||
| 5 | PK428 h | H | NP 003598 | PK428 h, MRCK r; mytonic dystrophy kinase Cdc42-bind | AGC | DMPK | 496 | 1q41-42 (ref UI: 97248557 ) | DMPK2 h 98%; MRCKb r 76% | |||||||||||||||||||
| 6 | CITRON-K | M | AAC27933 | Citron Kinase, Nature 394; 491-494 (1998) | AGC | DMPK | 1641 | NA | ||||||||||||||||||||
| 7 | DMPK h | H | Q09013 | Myotonic dystrophy (MTPK), DMK, MT-PK, DM-KINASE | AGC | DMPK | 639 | 19q13.3 (gene list) | ||||||||||||||||||||
| 8 | DMPK2 h | H | CAA73006 | DMPK2 h | AGC | DMPK | 289 | 11q13 (entrez 2217968) | 288aa MRCK r 74%; PK428 h 73%; MRCKb r 71% | |||||||||||||||||||
| 9 | MRCKb h | H | NP 006026 | MRCKb h, CDC42BP, myotonic dystrophy kinase-related CDC42-binding protein kinase beta, Genghis Khan dm | AGC | DMPK | 1711 | NA | 135aa MRCKb r 100%; PK428 h 88% | |||||||||||||||||||
| 10 | p160 ROCK2 h | H | NP 004841 | p160 ROCK2 h | AGC | DMPK | 1388 | NA | 135aa p160ROCK m 94% | |||||||||||||||||||
| 11 | ROCK1 h | H | NP 005397 | Rho-assoc coiled-coil kinase 1 | AGC | DMPK | 1354 | NA | ||||||||||||||||||||
| 12 | GRKpsu h | H | psu | GRKpsu h | AGC | GRK | na | NA | ||||||||||||||||||||
| 13 | RHODK h | H | NP 002920 | Rhodopsin kinase, RHOK, GRK1 | AGC | GRK | 563 | 13q34 (gene list) | ||||||||||||||||||||
| 14 | BARK1A h | H | NP 001610 | BARK1A h | AGC | GRK | 689 | 11q13 (GDB Gene List) | ||||||||||||||||||||
| 15 | BARK2 h | H | CAA48870 | BARK2 h | AGC | GRK | 688 | |||||||||||||||||||||
| 16 | GRK4 h | H | AAC50406 | GRK4 h, GPRK4 | AGC | GRK | 578 | 4p16.3 (gene list) | ||||||||||||||||||||
| 17 | GRK5 h | H | AAA58620 | GRK5 h | AGC | GRK | 590 | 10q24-10qter (gene list) | ||||||||||||||||||||
| 18 | GRK6 h | H | AAA60175 | GRK6 h | AGC | GRK | 576 | 5q35-5qter (gene list) | ||||||||||||||||||||
| 19 | GRK7 sq | SQ | AF063016 | GRK7 G protein-coupled receptor kinase | AGC | GRK | 548 | 258/526 (49%) GRK6 h | ||||||||||||||||||||
| 20 | KIAA0303 h | H | 2224547 | KIAA0303, MAST205 | AGC | MAST | 2137 | 5q12 (U) | KIAA0303 h 100% MAST205 m 91% | |||||||||||||||||||
| 21 | KIAA0561 h | H | BAA25487 | KIAA0561, R32140 1 | AGC | MAST | 1308 | 19p13.2 (E) | 274aa KIAA0303 h 90%; MAST205 m 90% | |||||||||||||||||||
| 22 | SAST h | H | BAA76817 | KIAA0973, SAST, syntrophin-associated STK, AF077818 m | AGC | MAST | 1583 | |||||||||||||||||||||
| 23 | MNK1 h | H | NP 003675 | MNK1, MAPK interacting kinase, MAP kinase-activated protein kinase | AGC | MNK | 424 | 1p31.1-32.3 (U) | ||||||||||||||||||||
| 24 | MNK2 h | H | AAD21217 | MNK2 | AGC | MNK | 472 | 19ptel (U) | ||||||||||||||||||||
| 25 | I38214 h | H | CAA80911 | 34aa PCR frag | AGC | MNK | 34 | NA | 34aa MNK1 82% | |||||||||||||||||||
| 26 | KIAA0151 h | H | BAA09772 | KIAA0151 | AGC | 716 | 1q31 (U) | 372aa IKKb h & IKKa h 27%; ULK h 31% | ||||||||||||||||||||
| 27 | T2K | M | AF145705 | T2K protein kinase homolog | AGC | 729 | 351/717 (48%) KIAA0151 h; 98/356 (27%) IKKb h | |||||||||||||||||||||
| 28 | TEST1 | H | est | TEST1, AAADYRP, KIAA0151-like | AGC | NA | 53aa KIAA0151 86%; M03C11.1 ce 42% | |||||||||||||||||||||
| 29 | NDR h | H | CAA84485 | NDR | AGC | NDR | 465 | 6p21.1-p21.3 (U) | ||||||||||||||||||||
| 30 | WART1 h | H | NP 004681 | WART1, lats1 h | AGC | NDR | 1130 | 6q22.3 (U) | ||||||||||||||||||||
| 31 | WART2 h | H | SUGEN | WART2 h | AGC | NDR | 12p13.1-13.3 | |||||||||||||||||||||
| 32 | PKX1 h | H | P51817 | PKX1 | AGC | PKA | 358 | Xp22.3 | 272aa PRKY h 92%; DC2 dm 62%; PKACb h 55% | |||||||||||||||||||
| 33 | PKACa h | H | CAA30597 | PKACa | AGC | PKA | 351 | 19p13.1 (gene list) | ||||||||||||||||||||
| 34 | PKACb h | H | AAA60170 | PKACb | AGC | PKA | 351 | 1p36.1 (gene list) | ||||||||||||||||||||
| 35 | PKACg h | H | AAC41690 | PKACg | AGC | PKA | 360 | 9q13 | ||||||||||||||||||||
| 36 | PKA-Cxpsu | M | psu | PKA-Cxpsu | AGC | PKA | M | |||||||||||||||||||||
| 37 | PRKXpsu h | H | psu | PRKXpsu h Pseudogene | AGC | PKA | na | 15q26 | 140aa PKX1 h 75%; DC2 dm | |||||||||||||||||||
| 38 | PRKY h | H | 2695984 | PRKX, PRKY, PKX1-like | AGC | PKA | 277 | Yp11.2 (E) | ||||||||||||||||||||
| 39 | CAB43292 h | H | CAB43292 | PKCmu? DKFZp586E0820, Contig w AA290809 | AGC | PKC | 542 | 19q13.1-q13.3 (U) | PKC mu 87.3% good seq | |||||||||||||||||||
| 40 | EPK2 h | H | NP 005804 | PKD h EPK2, PKCnu, a new member of the protein kinase C family, composes a fourth subfamily with PKC&mgr;1 | AGC | PKC | 890 | |||||||||||||||||||||
| 41 | EPK2 m | M | est | EPK2 h1 (AB015982) EPK2, PKCnu, a new member of the protein kinase C family, composes a fourth subfamily with PKC&mgr;1 | AGC | PKC | na | M | 109aa 97% EPK2 h 328bp 91% | |||||||||||||||||||
| 42 | PCKl h | H | AAA60100 | PKC lambda | AGC | PKC | 682 | 14 (U) | ||||||||||||||||||||
| 43 | PKCa h | H | CAA36718 | PKC alpha | AGC | PKC | 672 | 17q24.3 (G) 17q22-17q23.2 (g list) | ||||||||||||||||||||
| 44 | PKCb h | H | CAA30130 | PKC beta | AGC | PKC | 673 | 16p12.1 (G) | ||||||||||||||||||||
| 45 | PKCd h | H | BAA01381 | PKC delta | AGC | PKC | 626 | 3p14.3 (U) | ||||||||||||||||||||
| 46 | PKCe h | H | CAA46388 | PKC epsilon | AGC | PKC | 737 | NA | ||||||||||||||||||||
| 47 | PKCg h | H | CAA78820 | PKC gamma | AGC | PKC | 536 | 19q13.4 (gene list) | ||||||||||||||||||||
| 48 | PKCi h | H | AAB17011 | PKC iota | AGC | PKC | 587 | Xq21.3 (gene list iota) | ||||||||||||||||||||
| 49 | PKCm h | H | CAA53384 | PKC mu | AGC | PKC | 912 | 14q11.2-12 (U) | ||||||||||||||||||||
| 50 | PKCt h | H | AAA75571 | PKC theta | AGC | PKC | 706 | 10p15 (gene list) | ||||||||||||||||||||
| 51 | PKCz h | H | CAA78813 | PKC zeta | AGC | PKC | 584 | 1p36.3 (U) | ||||||||||||||||||||
| 52 | PKD m | M | CAA84283 | PKD | AGC | PKC | 918 | M | 918aa PKCmu h 92% | |||||||||||||||||||
| 53 | PRK1 h | H | I53327 | PRK1, PKN, DBK, PRK1.1 | AGC | PKC | 942 | 19p12-13.1 (U) | 942aa PRK1 h (PKN) 59% | |||||||||||||||||||
| 54 | PRK2 h | H | AAB33346 | PRK2 | AGC | PKC | 984 | 1p31.1 (G) 262cR from top | 942aa PRK1 h (PKN) 59% | |||||||||||||||||||
| 55 | Z25429 | H | CAA80916 | SETHKNI (I38219) | AGC | PKC | 67 | NA | 164aa PKCmu h 93%: 58aa I38219 h 100% | |||||||||||||||||||
| 56 | CGK h | H | CAA68810 | CGMP1, PKG h, KGPB h, CGK, PRKG1 (was CGK h) CGMP-DEPENDENT PROTEIN KINASE, BETA ISOZYME | AGC | PKG | 686 | 10q11.2 (gene list) | ||||||||||||||||||||
| 57 | cGMPk h | H | BAA08297 | PRKG2 | AGC | PKG | 671 | 4q13.1-4q21.1 (gene list) | ||||||||||||||||||||
| 58 | cGMPKII h | H | NP 006250 | cGMPKII | AGC | PKG | 762 | 4q21.1-q21.2 (U) | 145aa cGMPKPh 100% | |||||||||||||||||||
| 59 | AAD30182 | H | AAD30182 | 5/13/1999 - Genomic | AGC | S6K | 549 | RSK3 m 71/172 (41%) & 42/143 (29%) | ||||||||||||||||||||
| 60 | MSK1 h | H | NP 004746 | MSK1 h, RSK-like protein kinase RLPK, nuclear mitogen- and stress-activated protein kinase-1 | AGC | S6K | 809 | NA | 153aa S6K h 61%; T01H8.1b ce 62% | |||||||||||||||||||
| 61 | MSK2 h | H | NP 003933 | MSK2 h, RSK-B, mitogen- and stress-activated protein kinase-2, ribosomal protein S6 kinase, 90kD, polypeptide 4 | AGC | S6K | 772 | Xp22 (Entrez) | 710aa MSK1 h 71%; RSK3 h 43% | |||||||||||||||||||
| 62 | p70S6K h | H | AAA36410 | p70S6KaII h | AGC | S6K | 525 | 17q23.1-17q24.1 (G) | ||||||||||||||||||||
| 63 | p70S6Kb h | H | NP 003943 | p70S6 kinase b, p70 ribosomal S6 kinase beta, SRK, RPS6KB2 | AGC | S6K | 495 | |||||||||||||||||||||
| 64 | RSK1 h | H | CAA59427 | RSK h; S6K2 | AGC | S6K | 733 | 3pter-3qter (gene list) | ||||||||||||||||||||
| 65 | RSK2 h | H | AAA81952 | RSK2 h; ISPK-1 (insulin-stimulated) S6KII-a, p90RSK2 | AGC | S6K | 740 | Xp21.3-22.1 (Entrez) Chr1, 94.8cR (U) | ||||||||||||||||||||
| 66 | RSK3 h | H | AAC82497 | RSK3 h, ribosomal protein S6 kinase 3 m, p90 S6 kinase r | AGC | S6K | 735 | 6q27 (gene list) | ||||||||||||||||||||
| 67 | MAST205 m | M | AAC04312 | MAST205 m | AGC | SGK | 1734 | M | 274aa - AB002301 h 91% | |||||||||||||||||||
| 68 | SGK h | H | CAA71138 | SGK | AGC | SGK | 431 | 6q21-q22.1 | 431aa SGK r 96%; W10G6.2 ce 52%; AKT m 46% | |||||||||||||||||||
| 69 | A6 h | H | A55922 | A6 tyrosine kinase | Atypical | A6 | 350 | 12 (U) | 350aa A6 m (U82324) 94%; U46668 ce 31%; YGR080w sc 26% | |||||||||||||||||||
| 70 | EEF-2K | H | O00418 | Elongation factor kinase, Myosin heavy chain kinase | Atypical | MHCK | 725 | |||||||||||||||||||||
| 71 | BCKDK h | H | NP 005872 | BCKDK, branched chain alpha-ketoacid dehydrogenase kinase | Atypical | PDK | 412 | |||||||||||||||||||||
| 72 | PDK1 h | H | Q15118 | PDK1, pyruvate dehydrogenase kinase isoenzyme 1 | Atypical | PDK | 436 | |||||||||||||||||||||
| 73 | PDK2 h | H | NP 002602 | PDK2, pyruvate dehydrogenase kinase isoenzyme 2 | Atypical | PDK | 407 | |||||||||||||||||||||
| 74 | PDK3 h | H | NP 005382 | PDK3, pyruvate dehydrogenase kinase isoenzyme 3 | Atypical | PDK | 406 | |||||||||||||||||||||
| 75 | PDK4 h | H | NP 002603 | PDK4, pyruvate dehydrogenase kinase isoenzyme 4 | Atypical | PDK | 411 | |||||||||||||||||||||
| 76 | BCR h | H | P11274 | Domains=PH, C2, GAP (for p21-Rac) | Atypical | Unique | 1271 | 22q11 | ||||||||||||||||||||
| 77 | FAST h | H | I37386 | FAST, fas-activated STK (substrate=TIA1) | Atypical | Unique | 549 | 7q32-q36 (EST=AI126915) | 232aa CPR2 h 30% | |||||||||||||||||||
| 78 | GS3955 h | H | BAA13250 | GS3955 | CAMK | AMPK | 343 | 2p23-p22 (U) | 226aa GS3955 h (D87119) 100%; AJ000480 h 71%; PK38 m 32% | |||||||||||||||||||
| 79 | PK38 h | H | BAA11492 | PK38 h, MELK m | CAMK | AMPK | 651 | 9q11 (U) | KIAA0175 h 100% PK38 m 99% AMPKa1 r 49% | |||||||||||||||||||
| 80 | AMPKa1 h | H | NP 006242 | AMPKa1 | CAMK | AMPK | 550 | 5p14-5p11 (gene list) | 131aa AMPKa1 r 98% AMPK h 89% | |||||||||||||||||||
| 81 | AJ006701 h | H | CAA04119 | AJ006701 h, PEN11B h, F15A2.6 ce? | CAMK | AMPK | 224 | 11p15 | 444aa AJ006701 h, 97% (1950bp 99%); F15A2.6 ce48%; YKL101W sc 42% | |||||||||||||||||||
| 82 | AMPK2 h | H | 726313 | AMPK2, AAK2 | CAMK | AMPK | 108 | NA | ||||||||||||||||||||
| 83 | AMPKa2 h | H | AAA64745 | AMPKa2 | CAMK | AMPK | 552 | 1p31 (gene list) | ||||||||||||||||||||
| 84 | AUF1 h | H | NP 002129 | AUF1, AU-rich RNA binding protein | CAMK | AMPK | 286 | NA | 440 naAUF1 h 95%; PK38 m/Melk 38% | |||||||||||||||||||
| 85 | NIPK | R | AB020967 | NIPK induced by NGF-depletion | CAMK | AMPK | 349 | 155/290 (53%) GS3955 h | ||||||||||||||||||||
| 86 | U13258 | M | est | ink76 m partial GB 1994 | CAMK | AMPK | M | 64aa - AMPKa h 84.4%; | ||||||||||||||||||||
| 87 | AL049688 | H | CAB41259 | Ca2+/Calmodulin dependent Protein Kinase LIKE protein, CAA19296.1 h, BAA19880 r | CAMK | CAMK | 481 | |||||||||||||||||||||
| 88 | CaMKI h | H | Q14012 | CAMK1 | CAMK | CAMK | 370 | 3p24.2-p21.3 (U) | 314aa CaMKIb2 r 69%; CaMKIV h 49% | |||||||||||||||||||
| 89 | CaMKIb2 h | H | BAA19879 r | CAMK1b2 | CAMK | CAMK | 342 | NA | 161 aa CAMKIb2 r 97%, 480 bp 89% | |||||||||||||||||||
| 90 | CaMKIIa h | H | BAA76812 | CaMKIIa | CAMK | CAMK | 527 | NA | 90aa CaMKIIa m 100% in C-term | |||||||||||||||||||
| 91 | CaMKIIb h | H | AAD03743 | CaMKIIb h | CAMK | CAMK | 517 | 22q12 (LocusLink) | 169aa CAMKIIb m 99.4% | |||||||||||||||||||
| 92 | CaMKIId h | H | AAD20442 | CaMKIId h | CAMK | CAMK | 499 | NA | 155aa CKII delta 2 r 99% | |||||||||||||||||||
| 93 | CaMKIIg h | H | B46619 | CaMKIIg (+isoforms) | CAMK | CAMK | 518 | 10q22 (LocusLink) | ||||||||||||||||||||
| 94 | CAMKL h | H | AAA16633 r | Calmodulin-BP r (I56542), 1G5 | CAMK | CAMK | 504 | NA | 60aa Calmod bind r (I56542 r), 100%; 90aa CAMKI h 42% | |||||||||||||||||||
| 95 | CAMKL1 h | H | NP 004725 | KIAA0369, CPG16 r, doublecortin (lissencephalin-X; LISX ) and CaM kinase-like 1, AL110501 ce | CAMK | CAMK | 729 | 13q13 (U) | 281aa CAMK1 h 46% | |||||||||||||||||||
| 96 | CASK h | H | AAA64745 | CASK, CASK-B, lin-2, CAMGUK | CAMK | CAMK | 897 | Xp11.4 (LocusLink) | 268aa CASKb m 100% CAMKIId r 48% | |||||||||||||||||||
| 97 | CHK2 h | H | AAC83693 | CHK2 h w FHA domain, HuCds | CAMK | CHK2 | 543 | CaMK, 21/32 (65%) | ||||||||||||||||||||
| 98 | DAPK h | H | CAA53712 | DAPK h | CAMK | DAPK | 1431 | 9q34.1 (gene list) | ||||||||||||||||||||
| 99 | DAPKRP1 h | H | AAC35001 | DAPKRP1 | CAMK | DAPK | 370 | NA | 123aa DAPK h 78%; 78%na to N23936 | |||||||||||||||||||
| 100 | DRAK1 | H | NP 004751 | DRAK1, related to death-associated protein kinase that trigger apoptosis | CAMK | DAPK | 414 | 7p11.1-q11.1 (U) | 107aa DAPK h 47% SUGEN 8/3/98 GB:11/5/98 | |||||||||||||||||||
| 101 | DRAK2 h | H | NP 004217 | DRAK2, related to death-associated protein kinase that trigger apoptosis | CAMK | DAPK | 372 | NA | 81%na to AA538060 m, SUGEN:7/23/98, GB:11/5/98 | |||||||||||||||||||
| 102 | ZIP h | H | BAA24817 | LZK, ZIP, DAPK3 | CAMK | DAPK | 966 | 19p13.3 (LocusLink) | ||||||||||||||||||||
| 103 | KIAA0135 h | H | BAA09484 | KIAA0135 | CAMK | EMK | 1241 | 2q34-q37.2 (U) | 263aa KIAA0135 h 100% YAL017W sc 39% TAK 35% | |||||||||||||||||||
| 104 | KIAA0096 h | H | BAA07744 | KIAA0096 h | CAMK | EMK | 527 | 3p22.1 (G) | 34aa KIAA0096 h 76% (SNF1 r) | |||||||||||||||||||
| 105 | C-TAK1 | H | AAC15093 | C-TAK1, MARK3, Kp78, cTAK75a | CAMK | EMK | 729 | 14q32.1-32.3 (U) | ||||||||||||||||||||
| 106 | EMK h | H | CAA66229 | EMK h, ELKL motif kinase 1, KEM m, MARK2 r | CAMK | EMK | 745 | 11q12-11q13 (gene list) | ||||||||||||||||||||
| 107 | KIAA0537 h | H | BAA25463 | KIAA0537 h human orthologue of B04496 ce | CAMK | EMK | 661 | 12q22 (U) | 84 aa B0496 ce 64%,60 aa p78 h 55% | |||||||||||||||||||
| 108 | KIAA0999 | H | BAA76843 | KIAA0999 | CAMK | EMK | 1102 | 86/310 (60%) MSK m/SIK r | ||||||||||||||||||||
| 109 | MAK-V h | H | AF055919 | MAK-V m (AF055919), R25-38-5 m | CAMK | EMK | 714 m | 21q11.1 (AP000036) | 300aa MAK-V m >91%; SPCC74 sp 48%; TAK1 h 31% | |||||||||||||||||||
| 110 | MARK1 h | H | CAB06294 | MARK1 r | CAMK | EMK | 793 r | NA | 181aa TAK1 h 90%, 492bp MARK1 r 91% | |||||||||||||||||||
| 111 | MSK m | M | Q60670 | MSK, HRT-20, Myocardial SNF1-like kinase | CAMK | EMK | 481 | M | 80aa p78 h 60% | |||||||||||||||||||
| 112 | SNRK h | H | CAA61563 | SNRK h | CAMK | EMK | 746 r | NA | SNRK r >98% SNF-related | |||||||||||||||||||
| 113 | MAPKAPK2 h | H | P49137 | MAPKAPK2, MKK2 | CAMK | MAPKAP | 370 | 1q32.1-q32.2 (G) | ||||||||||||||||||||
| 114 | MAPKAPK3 h | H | AAD09136 | MAPKAPK3, 3PK | CAMK | MAPKAP | 382 | 3p21.3 (G) | ||||||||||||||||||||
| 115 | MAPKAPK5 h | H | NP 003659 | MAPKAPK5, PRAK, PRK | CAMK | MAPKAP | 471 | 12q22 (U) | 132aa MAPKAP2 h 50%; MAPKAPK3 h 44%; CAMK4 h 39% | |||||||||||||||||||
| 116 | MLCK h | H | AAC18423 | MLCK | CAMK | MLCK | 1914 | 3q13.3 (U) | ||||||||||||||||||||
| 117 | MLCKs | R | AAA41625 | Myosin LCK skel muscle | CAMK | MLCK | 610 r | 99aa MLCK rat 97% | ||||||||||||||||||||
| 118 | Titin h | H | NP 003310 | Titin | CAMK | MLCK | 26926 | 2q31 (E) | ||||||||||||||||||||
| 119 | PHKG1 h | H | Q16816 | PHKG1, phosphorylase kinase gamma 1 | CAMK | PHK | 387 | 7p12-7q21 (gene list) | 271aa - PHKG1-Testis h 71% Exact to skel mus form | |||||||||||||||||||
| 120 | PHKgT h | H | P15735 | PHKgT, PHKG2, PSK-C3, phosphorylase kinase gamma 2 | CAMK | PHK | 406 | 16p12.1-p11.2 (U) | 372aa PHKG1 h 64%; CAMKI r 39% | |||||||||||||||||||
| 121 | PSK-H1 h | H | 406242 | PSK-H1 | CAMK | PHK | 319 | NA | ||||||||||||||||||||
| 122 | Trio h | H | 1353703 | Trio | CAMK | Trio | 2861 | 5p15.1-p14 (ref Taviaux) | Trio h 100% DAPK1 h 42% | |||||||||||||||||||
| 123 | TRAD h | H | BAA76314 | TRAD; Duet is a novel STK with dbl- (DH) and pleckstrin- (PH) domains (3/99) | CAMK | Trio | 1289 | NA | 1203aa Trio h ~50% SUGEN 9/2/98 GB:3/24/99 | |||||||||||||||||||
| 124 | KIAA0369 h | H | BAA20824 | KIAA0369 h CPG16 | CAMK | Unique | 729 | 13q13 (U) | KIAA0369 h CAMKI h 47% | |||||||||||||||||||
| 125 | CKIg2 h | H | AAB88627 | CKIg2, Casein Kinase 1 gamma 2 h | CKI | CKI | 415 | 19p13.3 (gene list) | ||||||||||||||||||||
| 126 | CKIa h | H | AAC41760 | casein kin 1 alpha | CKI | CKI | 337 | 13q13 (gene list) | ||||||||||||||||||||
| 127 | CKId h | H | AAC50807 | casein kin 1 delta | CKI | CKI | 415 | 17q25.2-17q25.3 (gene list) | ||||||||||||||||||||
| 128 | CKIe h | H | AAC41761 | casein kin 1 epsilon | CKI | CKI | 416 | 22q12-22q13 (gene list) | ||||||||||||||||||||
| 129 | KKIAMRE h | H | AAC50918 | KKIAMRE, p56 | CMGC | CDK | 493 | NA | 308aa KKILARE h 58%; PISSLRE h 38% | |||||||||||||||||||
| 130 | CAK h | H | P50613 | CAK, CDK7, Mo15, STK1, p39 | CMGC | CDK | 346 | 2p15-cen (LocusLink) | 290aa CDK3 h 46% | |||||||||||||||||||
| 131 | CCRK h | H | AAC98920 | CCRK cell cycle related kinase | CMGC | CDK | 452 | NA | 462aa CCRK h (AF035013) 99%, 1331bp 98%; CDK3 h 44% | |||||||||||||||||||
| 132 | CDC2 h | H | P06493 | CDC2, MPF, M-phase kinase, CDK1 | CMGC | CDK | 297 | 10q21.1 (U) | ||||||||||||||||||||
| 133 | CDK2 h | H | AAA35667 | CDK2 | CMGC | CDK | 298 | 12q13 (gene list) | ||||||||||||||||||||
| 134 | CDK3 h | H | Q00526 | CDK3 | CMGC | CDK | 305 | 17q22-qter (LocusLink) | ||||||||||||||||||||
| 135 | CDK4 h | H | P11802 | CDK4, PSK-J3 | CMGC | CDK | 303 | 12q13.2-q13.3 (U) 12q14 (LocusLink) | ||||||||||||||||||||
| 136 | CDK5 h | H | Q00535 | CDK5, PSSALRE, TPKII (Tau protein kinaseII) | CMGC | CDK | 291 | 7q36 (gene list) | ||||||||||||||||||||
| 137 | CDK6 h | H | Q00534 | CDK6, PLSTIRE | CMGC | CDK | 326 | 7q21.1-q21.3 (U) | ||||||||||||||||||||
| 138 | CDK8 h | H | CAA59754 | CDK8 h | CMGC | CDK | 464 | 13q12 (gene list) | ||||||||||||||||||||
| 139 | CHED h | H | AAA58424 | CHED, cdc2-related | CMGC | CDK | 418 | NA | 320aa PITALRE h 46%; CDK3 h 43% | |||||||||||||||||||
| 140 | KIAA0904 | H | BAA74927 | KIAA0904 (2/20/99) CHED! Novel | CMGC | CDK | 997 | NA | 201 aa CHED h 90% | |||||||||||||||||||
| 141 | KKILARE h | H | CAA47002 | KKILARE h | CMGC | CDK | 358 | NA | 308aa KKIAMRE h 58%; CDK3 h 43% | |||||||||||||||||||
| 142 | PCTAIRE1 h | H | S22747 | PCTAIRE1 h | CMGC | CDK | 496 | Xp11.3-Xp11.23 (gene list) | ||||||||||||||||||||
| 143 | PCTAIRE2 h | H | S22746 | PCTAIRE2 h | CMGC | CDK | 523 | NA | ||||||||||||||||||||
| 144 | PCTAIRE3 h | H | CAA47005 | PCTAIRE3 h | CMGC | CDK | 380 | 1q31-1q32 (gene list) | ||||||||||||||||||||
| 145 | PFTAIRE h | H | BAA74857 | PFTAIRE1 h G20041, KIAA0834 | CMGC | CDK | 451 | 7q21-22 (gene list) | 218aa PFTAIRE1 m 99% 708bp 91%PFTAIRE m (95%) | |||||||||||||||||||
| 146 | PISSLRE h | H | S49330 | PISSLRE, PK2J, CDK10 | CMGC | CDK | 360 | 16q24 (LocusLink) | ||||||||||||||||||||
| 147 | PITALRE h | H | AAA58424 | PITALRE, C-2K, CDK9, P-TEFb kinase | CMGC | CDK | 418 | 9q34.1 (LocusLink) | 320aa CHED 47% | |||||||||||||||||||
| 148 | PITSLREa2 h | H | P21127 | PITSLREa2-1,2,3,4,a1,b; PBETA21,22; P58/GTA; p58clk-1, galactosyltransferase-associated kinase | CMGC | CDK | 439 | 4p14-p15.1 (U) | ||||||||||||||||||||
| 149 | STK9 | H | NP 003150 | STK9, novel sSTK from the Xp22 region | CMGC | CDK | 1030 | Xp22 | ||||||||||||||||||||
| 150 | CLK1 h | H | AAA61480 | CLK1, CLK1-136, cdc2-cdc28-like | CMGC | CLK | 484 | NA | ||||||||||||||||||||
| 151 | CLK2 h | H | AAC51817 | L29218 | CMGC | CLK | 499 | 1q21 (LocusLink) | ||||||||||||||||||||
| 152 | CLK3 h | H | AAA61484 | CLK3 h | CMGC | CLK | 490 | Chr.15 | ||||||||||||||||||||
| 153 | CLK4 h | H | est | CLK4 | CMGC | CLK | NA | 322aa CLK4 m 98%, CLK1 h 86% see AA773376 for N-term | ||||||||||||||||||||
| 154 | STY | M | A39676 | STY, TF-STY, CLK1 m, nuclear dual spec kin | CMGC | CLK | 483 | NA | 136aa STY m 93%; CLK1 h 78% | |||||||||||||||||||
| 155 | GSK3a h | H | AAA62432 | GSK3a | CMGC | GSK | 483 | 19q12-q13.4 (U) | ||||||||||||||||||||
| 156 | GSK3b h | H | AAA66475 | GSK3b h | CMGC | GSK | 420 | 3q13.3 (U) | ||||||||||||||||||||
| 157 | ERK1 h | H | CAA42744 | ERK1, MAPK1, p44MAPK | CMGC | MAPK | 379 | 16p11.2-16p11.2 (gene list) | ||||||||||||||||||||
| 158 | ERK2 h | H | CAA77753 | ERK2, MAPK2, p42MAPK, 40KDAP | CMGC | MAPK | 348 | 22p11.2-q11.2 (U) | ||||||||||||||||||||
| 159 | ERK3 h | H | Q16659 | ERK3a, p97MAPK h, p55MAPK r | CMGC | MAPK | 721 | 15q21 (ref Meloche) | 464aa 61% ERK4 h; ERK2 h 45%; ERK1 h 44% | |||||||||||||||||||
| 160 | ERK4 h | H | P31152 | ERK4, p63MAPK | CMGC | MAPK | 557 | 18q12.3-q21.2 (U) | ||||||||||||||||||||
| 161 | ERK5 h | H | Q13164 | ERK5, SAPK5, BMK1 | CMGC | MAPK | 816 | 17p11.2-17q11.2 (U) | 330aa ERK1 h 51%; ERK2 h 51% | |||||||||||||||||||
| 162 | ERK7 r | R | AAD12719 | ERK7 r, 04-FEB-1999, SLT2 sc | CMGC | MAPK | 546 | 452aa SLT2 sc 34$ 340aa ERK1 h 40% | ||||||||||||||||||||
| 163 | JNK1a h | H | AAA36131 | JNK1a, SAPKg | CMGC | MAPK | 384 | 10q11.23 (G) D10S1754-1793 (U) | ||||||||||||||||||||
| 164 | JNK2 h | H | P45984 | JNK2, JNK2a, JNK2b, SAPKa, JNK-55 | CMGC | MAPK | 424 | 5q35 (OMIM) | ||||||||||||||||||||
| 165 | JNK3a h | H | AAC50101 | JNK3a1, JNK3a2, SAPKb, p54b, p493F12 | CMGC | MAPK | 422 | 4q21.3 (U) | ||||||||||||||||||||
| 166 | NLK h | H | AAC24499 | NLK h, DRES 16 | CMGC | MAPK | 515 m | |||||||||||||||||||||
| 167 | p38 h | H | AAA57455 | p38, SAPK2a, CSBP2, Mxi2, MPK2 xl | CMGC | MAPK | 360 | 6p21.1-p21.3 (U) | ||||||||||||||||||||
| 168 | SAPK2b h | H | AAB05036 | SAPK2b, p38b2, p38-2 | CMGC | MAPK | 372 | NA | ||||||||||||||||||||
| 169 | SAPK3 h | H | CAA71511 | SAPK3, ERK6, p38gamma | CMGC | MAPK | 367 | 22q13.3 (gene list) | 345aa SAPK4 h 66%; p38 h 62% | |||||||||||||||||||
| 170 | SAPK4 h | H | NP 002745 | SAPK4 h, p38 delta, PRKM13, stress-activated protein kinase SAPK4 | CMGC | MAPK | 365 | NA | ||||||||||||||||||||
| 171 | KIAA0936 | H | BAA76780 | KIAA0936 | CMGC | RCK | 632 | |||||||||||||||||||||
| 172 | MAK m | M | CAA47392 | RCK, MAK, MRK; M35863 (exon N) | CMGC | RCK | 622 | 6q22 gene list | 43aa - MAK m SP:Q04859 | |||||||||||||||||||
| 173 | MOK | H | BAA81688 | MOK protein kinase, homology to MRK, MAK, MAP kinases (ERK, p38, JNK/SAPK), Cdks; possesses TEY activation loop | CMGC | RCK | 419 | 129/324 (39%) MHK at; 121/327 (37%) MAK m | ||||||||||||||||||||
| 174 | RAGE4 h | H | AAB38087 | RAGE4 h | CMGC | Unique | 187 | 14q31-qtel (U) | 50aa RAGE-4 h 100% cdc2 r 40% | |||||||||||||||||||
| 175 | YAB1 | H | est | HYPOTHETICAL HEART PROTEIN | Microbial PK | ABC1 | ||||||||||||||||||||||
| 176 | SUDD | H | NP 003822 | sudD (suppressor of bimD6, Aspergillus nidulans) homolog (SUDD) | Microbial PK | RI01 | 519 | |||||||||||||||||||||
| 177 | NY-REN-64 | AAD42884 | putative protein kinase NY-REN-64 antigen (renal-cell carcinoma), phosphorylates tyrosine, serine and threonine | Other | APKA at | 460 | 111/283 (39%) APKA at (and others) | |||||||||||||||||||||
| 178 | AIE1 m | M | AAC25954 | AIE1 m AUR3 | Other | AUR | 282 | M | 280aa AUR1 h 78% | |||||||||||||||||||
| 179 | AIE2 h | H | AAC25955 | AUR3, STK13, Aik3, AIE2 | Other | AUR | 275 | 19q13.4 (Lamerdin) AC005261 | 67aa AUR1 h 74% | |||||||||||||||||||
| 180 | AUR1 h | H | NP 004208 | AUR1, ARK2 m, STK1 m | Other | AUR | 344 | 17p13.1 (Plowman) | ||||||||||||||||||||
| 181 | AUR2 h | H | AAC12708 | AUR2, BTAK, IAK1 m, AYK1 m, STK15 | Other | AUR | 403 | 20q13.2 (Plowman) | ||||||||||||||||||||
| 182 | AUR1psu h | H | psu | AUR1psuedogene | Other | AURps | pseudo | |||||||||||||||||||||
| 183 | AUR2psu h | H | psu | AUR2 pseudogene, B59754 genomic | Other | AURps | pseudo | |||||||||||||||||||||
| 184 | BUB1 | H | AAB97855 | BUB1 | Other | BUB | 1085 | 2q11.1 (Spencer) | ||||||||||||||||||||
| 185 | BUBR1 h | H | AAC12730 | BUBR1, MAD3L, SSK1, BUB1B, MAD3-like kinase, mitotic checkpoint protein kinase, AF107296 m | Other | BUB | 1050 | 15q14-21 | 514aa BUB1 h 24% | |||||||||||||||||||
| 186 | GSG2 m | M | D87326 | GSG2, expressed in testicular germ cells | Other | C26C2.1 ce | 754 | 104/286 (36%) F22H10.5 ce | ||||||||||||||||||||
| 187 | CaMKIV h | H | BAA04117 | CaMKIV, ca/calmod-dep pk IV, CAMKK | Other | CAMKK | 365 | 5q21-5q23 (gene list) | 346aa U11029 ce; SSP1 sp 37% | |||||||||||||||||||
| 188 | CAMKKB | H | AAD31507 | KIAA0787, CAMKKB Ca2+/calmodulin-dependent protein kinase kinase beta | Other | CAMKK | 588 | 12q23-q14.1 (U) | 271aa CAMKIV r 68%; U11029 ce 57% | |||||||||||||||||||
| 189 | CHK1 h | H | NP 001265 | CHK1 h (checkpoint, S.pombe) homolog | Other | CHK | 476 | NA | ||||||||||||||||||||
| 190 | CKIIa h | H | AAA35503 | casein kinase 2, alpha 1 | Other | CKII | 391 | 20p13 (gene list) | 35aa CKIIa h 83% | |||||||||||||||||||
| 191 | CKIIa' h | H | AAA51548 | casein kinase 2, alpha prime | Other | CKII | 350 | 16q13 (G) | ||||||||||||||||||||
| 192 | COT h | H | P41279 | COT | Other | COT | 467 | Chr.10, 185.3 cR (U) | ||||||||||||||||||||
| 193 | DYRK2 h | H | CAA73885 | Dyrk2 h | Other | DYRK | 528 | 12q14 (U) | ||||||||||||||||||||
| 194 | DYRK1B | H | NP 004705 | DYRK1B dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | Other | DYRK | 629 | 377/509 (74%) MNB h, DYRK r, DYRK1 h; 168/398 (42%) DYRK2 h | ||||||||||||||||||||
| 195 | DYRK3 h | H | NP 003573 | DYRK3 h dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 | Other | DYRK | 553 | NA | Dyrk3 h 100% DYRK2 h 77% | |||||||||||||||||||
| 196 | DYRK4 h | H | CAA70488 | dyrk4 | Other | DYRK | 240 | 12913.3-p13.2 (U) | Dyrk4 h 100% DYRK2 h 56% | |||||||||||||||||||
| 197 | HIPK1 h | H | AAC63010 | HIPK1 (homeodomain-interacting kinase) see AF077658 m, nuclear body associated kinase 2a, Myak-L m, Myak-S m; similar to yeast YAK1 | Other | DYRK | 1209 m | 22p11.2-q11.2 (U) | 1253 HIPK2 m 63%, HIPK3 m 46%, ANPK r 46%, PKY h 46% | |||||||||||||||||||
| 198 | HIPK2 m | M | AAC63011 | HIPK2 h, G30814 (STS) see AF077659 m | Other | DYRK | 1189 | 7 (E) | 1253 HIPK1 m 63% | |||||||||||||||||||
| 199 | KIS h | H | CAA67021 | KIS r (X98374) KIS m (Y10725) P-CIP2 (PAM COOH interacting) | Other | DYRK | 419 r | NA | 148 aa Dyrk2 h 36%, MNB dm 37% | |||||||||||||||||||
| 200 | MNB h | H | BAA13110 | MNB h,dual-specificity kinase, homolog of Drosophila mnb (minibrain) protein | Other | DYRK | 754 | 21q22.2 (Ref) | ||||||||||||||||||||
| 201 | PKY h | H | AAC64294 | PKY h AF004849, ANPK r, DYRK6, HIPK3 m (homeodomain-interacting protein kinase 3), NBAK3 (nuclear body associated kinase 3) | Other | DYRK | 1215 | NA | 1215aa ANPK r 88%, U41015 ce 67% | |||||||||||||||||||
| 202 | EIF2aK h | H | O00418 | P1/EIF-2aK, p68K, PKR, IFN-inducible RNA-dep kinase | Other | EIFK | 725 | 2p21 (U) | 553aa TIK m 57%; EIF2aK r 57% | |||||||||||||||||||
| 203 | EIF2aK m | M | Q08796 | EIF-2aK,TIK, p68K, 65kDa Kinase | Other | EIFK | 724 | M | 553aa p68K h 57%; EIF2aK r 76% | |||||||||||||||||||
| 204 | PEK h | H | AAD19961 | PEK (pancreatic eIF-2 alpha kinase); IFN-inducible (3/12/99), PERK m (AF076681) type-I transmembrane ER-resident STK AF096835 r | Other | EIFK | 1115 | NA | 57aa F46C3.1 ce 45%; p68 h 42% | |||||||||||||||||||
| 205 | GAK h | H | BAA22623 | GAK, cyclinG-assoc kinase | Other | GAK | 1311 | 4p16 (gene list) | GAK h (D88435) 100% GAK r 93% | |||||||||||||||||||
| 206 | IKKa h | H | AAC51671 | IKK1, IKK alpha, CHUK, Helix-loop-helix kinase | Other | IKK | 745 | 10q24-q25 (gene list) | 718aa IKKb h 50%; KIAA0151 h 28% | |||||||||||||||||||
| 207 | IKKb h | H | AAC51860 | IKKb h, IkB kinase-b | Other | IKK | 756 | NA | 190aa IKKb h 100% IKKa h 71% | |||||||||||||||||||
| 208 | ILK h | H | AAC16892 | Beta ILK, Integrin linked kinase | Other | ILK | 452 | 11p15.5-11p15.4 (gene list) | ILK h 100%; CTR1 at 28% | |||||||||||||||||||
| 209 | IRAK h | H | AAC41949 | IRAK | Other | IRAK | 712 | Xq28 (gene list) | ||||||||||||||||||||
| 210 | IRAK2 h | H | NP 001561 | IRAK2 interleukin-1 receptor-associated kinase 2 | Other | IRAK | 590 | 3p24.2-p21.3 (U) | IRAK2 h 100%IRAK1 h 28% | |||||||||||||||||||
| 211 | IRAK-M h | H | AAD40879 | IRAK-M, IL-1 receptor-associated-kinase-M | Other | IRAK | 596 | |||||||||||||||||||||
| 212 | IRE1 h | H | AAC25991 | IRE1, bifunctional kinase/endoribonuclease (Ire1p), ERN1, ER to nucleus signalling 1 | Other | IRE | 977 | NA | 402aa YOG4 ce; IRE1 sc 41%; 54%CAMKIId r 29%; PLK1 h 26% | |||||||||||||||||||
| 213 | LIMK2 h | H | BAA08312 | LIMK2 h, LIM Kinase 2 | Other | LIMK | 638 | 22q12 (gene list) | ||||||||||||||||||||
| 214 | TESK1 h | H | BAA09459 | testis-specific kinase | Other | LIMK | 626 | 200 aa 47% LIMK1 h | ||||||||||||||||||||
| 215 | LIMK1 h | H | AAC13884 | LIMK1 h | Other | LIMK | 258 | 7q11.23 (OMIM) | ||||||||||||||||||||
| 216 | LIMK2b m | M | BAA24489 | LIMK2b (2/23/99) LIMK2 isoform | Other | LIMK | 617 | M | 601aa LIMK2 h 95% | |||||||||||||||||||
| 217 | TESK2 h | h | CAB41970 | TESK2, LIMK/TESK family of protein kinases, predominantly expressed in testis | Other | LIMK | 555 | |||||||||||||||||||||
| 218 | LKB1 h | H | Q15831 | PJK, LKB1, STK1, XEEK1 xl, Peutz Jaeeger kinase | Other | LKB | 433 | 19p13.3 (OMIM) | ||||||||||||||||||||
| 219 | DLK h | H | AAA67343 | DLK h, ZPK | Other | MLK | 859 | 12q13 (U) | ||||||||||||||||||||
| 220 | HH498 | H | AAD29632 | HH498, AF116826, ankyrin repeats, MLK- like | Other | MLK | 835 | 140aa C24A1.3 ce 45% | ||||||||||||||||||||
| 221 | MLK1 m | M | P80192 | MLK1 h (Mixed lineage kinase), JU0229 | Other | MLK | 394 | 14q24.3-14q31 (gene list) | ||||||||||||||||||||
| 222 | MLK2 h | H | Q02779 | MLK2, MST, I38044, S68178 | Other | MLK | 237 | 19q13.2 (ref Dorow) | ||||||||||||||||||||
| 223 | SPRK h | H | AAA59859 | SPRK, MLK3, PTK1, A53800 | Other | MLK | 847 | 11q13.1-11q13.3 (gene list) | ||||||||||||||||||||
| 224 | MOS h | H | AAA52029 | MOS h | Other | MOS | 346 | 8q11 (OMIM) | ||||||||||||||||||||
| 225 | PIM2 h | H | AAC78506 | PIM2 h | Other | PIM | 334 | Xp12-p21.1 (U) | ||||||||||||||||||||
| 226 | KID1 h | H | BAA25182 | KID1 h | Other | PIM | 605 | 22q13-2-qtel | 146aa KID1 r 97% PIM1 h 82% | |||||||||||||||||||
| 227 | PIM1 h | H | AAA81553 | PIM1 h | Other | PIM | 313 | 6p21.2 (gene list) | ||||||||||||||||||||
| 228 | PRK h | H | AAC50637 | PRK h (FNK m) | Other | PLK | 607 | 1p32.3-p31.1 (U) | ||||||||||||||||||||
| 229 | SNK h | H | NP 006613 | SNK h , serum-inducible kinase | Other | PLK | 685 | 5q11.2 (U) | ||||||||||||||||||||
| 230 | PLK1 h | H | AAA56634 | PLK1 h | Other | PLK | 603 | NA | ||||||||||||||||||||
| 231 | SAK h | H | CAA73575 | SAK h | Other | PLK | 970 | 4q26 (U) | ||||||||||||||||||||
| 232 | PRP4 h | H | BAA25462 | PRP4h, KIAA0536, sp|Q135351, pre-mRNA splicing kinase | Other | PRP4 | 1028 | 6ptel (U) | 799aa F22D6.5 ce 41%; PRP4 sp 43% | |||||||||||||||||||
| 233 | KSR h | H | AAC50354 | KSR h , kinase suppressor of Ras | Other | RAF | 635 | NA | ||||||||||||||||||||
| 234 | ARaf h | H | AAA65219 | ARaf h | Other | RAF | 606 | Xp11.4-p11.2 | ||||||||||||||||||||
| 235 | BRaf h | H | AAA35609 | BRaf (417055, 323034) | Other | RAF | 765 | 7q34 (U) | ||||||||||||||||||||
| 236 | Raf1 h | H | CAA27204 | Raf1 h | Other | RAF | 648 | 3p25.1 (G) | ||||||||||||||||||||
| 237 | RAF2psu h | H | psu | RAF2psu h | Other | RAF | 239aa RAF1 h 66% | |||||||||||||||||||||
| 238 | HCYP2 r | R | AF036537 | homocysteine respondent protein HCYP2, homocysteine-respondent gene cloned from WKY VSMCs | Other | RIP | 142 | 103/142 (72%) RIP3 h | ||||||||||||||||||||
| 239 | KIAA0472 | H | BAA32317 | KIAA0472 | Other | RIP | 365 | 1q31 (U) | KIAA0472 100%; RIP m 29% (Q60855); FES h 30% (P07332) (CAT domain) | |||||||||||||||||||
| 240 | RICK h | H | NP 003812 | RICK h receptor-interacting serine-threonine kinase 2 containing a caspase recruitment domain | Other | RIP | 540 | M | 170aa RICK h 91% ; RIP h 37% | |||||||||||||||||||
| 241 | RIP h | H | 1236943 | RIP h | Other | RIP | 671 | NA | ||||||||||||||||||||
| 242 | RIP3 h | H | AAD39005 | RIP3, receptor-interacting protein 3 | Other | RIP | 518 | |||||||||||||||||||||
| 243 | SRPK2 h | H | NP 003129 | SRPK2 h A differentially expressed SR protein-specific kinase, SFRS protein kinase 2 | Other | SRPK | 686 | 7q22.1 (U) | ||||||||||||||||||||
| 244 | MSSK1 h | H | AAD01848 | muscle-specific serine kinase 1 | Other | SRPK | 533 | Xq28 | 360aa SRPK1 m 74%,135aa U52111 h 100%, SRPK1 h 70% | |||||||||||||||||||
| 245 | SRPK1 h | H | AAA20530 | SRPK h | Other | SRPK | 655 | 6p21.2 (gene list) | ||||||||||||||||||||
| 246 | ACTR-IIB4 h | H | CAA54671 | ACVR2B, ACTR-IIB4 h | Other | STKR | 512 | 3p22-3p21.3 (gene list) | ACTR IIB4 m 99% ACTR II h 99% | |||||||||||||||||||
| 247 | ALK6 h | H | AAC28131 | ALK6, Rpk1, R6 | Other | STKR | 502 | 4q22 (U) | ||||||||||||||||||||
| 248 | ACTR-II h | H | AAA35504 | ACTR-II h | Other | STKR | 513 | 2q21.1-q21.2 (U) | ||||||||||||||||||||
| 249 | ALK1 h | H | CAA02404 | ACVRL1, Activin like, Tsr-1, R3 | Other | STKR | 503 | 12q11-12q14 (gene list) | ||||||||||||||||||||
| 250 | ALK2 h | H | 2295238 | ALK2, ActR-1, Tsk7L, Skr1, R1 | Other | STKR | 509 | 2q22.3-q23.3 | ||||||||||||||||||||
| 251 | ALK3 h | H | CAA80257 | ALK3, Brk-1, Tfr11, R5, Skr5, BMPR1A | Other | STKR | 532 | 10q22.3 (Locuslink) | ||||||||||||||||||||
| 252 | ALK4 h | H | CAA80258 | ALK4, ActR-1B, R2, SKR2-1, SKR2-2 | Other | STKR | 505 | 12q11-13.2 (U) | ||||||||||||||||||||
| 253 | ALK5 h | H | AAA16073 | TGFbetaR1, TbR-1, R4, RPK2 | Other | STKR | 503 | 9q33-9q34.1 (gene list) | ||||||||||||||||||||
| 254 | ALK7 r | H | AAC52919 | ALK7, STKR6.22 | Other | STKR | 493 | |||||||||||||||||||||
| 255 | C14 | R | CAA50731 | C14, MISIIR r | Other | STKR | 557 | R | ||||||||||||||||||||
| 256 | MISRII h | H | AAC50328 | MISRII h | Other | STKR | 573 | 12q12-13.2 (U) | ||||||||||||||||||||
| 257 | T-ALK h | H | CAA88759 | T-ALK h | Other | STKR | 1038 | 2q33-q34 (LocusLink) | ||||||||||||||||||||
| 258 | TGFbRII h | H | BAA09332 | TGFbRII h | Other | STKR | 567 | 3pter-3p24.2 (gene list) | ||||||||||||||||||||
| 259 | TAK1 m | M | BAA11184 | TAK1 m, (see AA314749 h) | Other | TAK1 | 597 | NA | ||||||||||||||||||||
| 260 | TSK1 m | M | AAA99535 | TSK1, tssk-1 | Other | TSK | 364 | 335aa TSK2 m 76% | ||||||||||||||||||||
| 261 | TSK2 h | H | NA | TSK2 h, tssk-2, DGS-G; DiGeorge and velo-cardio-facial syndrome | Other | TSK | NA | 336aa TSK1 m 77% | ||||||||||||||||||||
| 262 | TSK3 m | M | est | TSK3 m - full-length | Other | TSK | M | 281aa TSK2 m 47% | ||||||||||||||||||||
| 263 | TSK4 h | H | est | TSK4 | Other | TSK | 14p11.1-q11.1 (U) | 75aa TSK1-h 52% | ||||||||||||||||||||
| 264 | PKUa h | H | BAA20561 | PKUa h | Other | TSL | 719 | 17 (SHGC) | PKUa h (MTT) 100% TSL at 60% | |||||||||||||||||||
| 265 | TSL1 h | H | BAA09486 | TSL1 h | Other | TSL | 549 | 2q24.1 (U) | ||||||||||||||||||||
| 266 | TTK h | H | AAA61239 | PYT, MPS1? | Other | TTK | 841 | NA | ||||||||||||||||||||
| 267 | ULK1 h | H | NP 003556 | ULK1 | Other | UNC | 1050 | NA | 1054aa ULK1 m 89%; KIAA0623 h 52%; UNC51 ce 43% | |||||||||||||||||||
| 268 | ULK2 h | H | BAA31598 | KIAA0623 h, ULK2 m (UNC-51 like kinase) | Other | UNC | 1036 | M | 110aa KIAA0623 h 100% (92%na); ULK1 h 74%; | |||||||||||||||||||
| 269 | VRK1 h | H | BAA19108 | VRK1 h vaccinia related kinase 1, similarity to vaccinia virus B1R kinase | Other | VRK | 396 | 14q32 (gene list) | ||||||||||||||||||||
| 270 | 51PK(L) m | M | AAC29497 | VRK1 m? 51PK(L), 51PK(S) | Other | VRK | 440 | M | ~100% 51PK(L) m; VRK1 h 87% (229bp 86%); VRK2 h 44% | |||||||||||||||||||
| 271 | VRK2 h | H | BAA19109 | VRK2 h | Other | VRK | 508 | 2p16-2p15 (gene list) | 273aa VRK2 h poor seq | |||||||||||||||||||
| 272 | MYT1 h | H | NP 004194 | MYT1 h, membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | Other | WEE | 499 | NA | MYT1 h 100% WEE1 h 59% | |||||||||||||||||||
| 273 | AC004918 | H | AAD04726 | similar to wee1-like protein kinase; PAC clone DJ0894A10 | Other | WEE | 541 | |||||||||||||||||||||
| 274 | WEE1 h | H | CAA43979 | WEE1 h | Other | WEE | 646 | 11p15.3-p15.1 (OMIM) | ||||||||||||||||||||
| 275 | MPSK1 h | H | AAC28337 | MPSK1, PKL12, PSK, EDPK, myristilated and palmitylated STK | Other | YPL236 sc | 305 | 3cen-3q21 (gene list) | 351aa YPL236c sc 29%; GAK h 29%; NEK1 m 28% | |||||||||||||||||||
| 276 | MPSK1psu h | H | psu | MPSK1psuedogene | Other | YPL236 sc | NA | 257aa MPSK1 h 77% w mult frameshifts | ||||||||||||||||||||
| 277 | PKN r | R | BAA36362 | PKN r C01C4.3 | Other | YWY3 ce | 417 | |||||||||||||||||||||
| 278 | NEK1 h | H | AAD42879 | NEK1 h | STE | NEK | 771 | NA | 223 aa NEK3 h P51956 58%; 250 aa NIMA en P11837 37% | |||||||||||||||||||
| 279 | NEK2 h | H | AAA19558 | NEK2 h | STE | NEK | 445 | 1q31-32.1 (U) | 310 aa NIMA en (P11837) 40% | |||||||||||||||||||
| 280 | NEK3 h | H | P51956 | NEK3 h, NIMA-related kinase NEK3 | STE | NEK | 459 | 13q14.3 (U) | 336/458 (73%) NEK3 m; 265 aa NEK1 m (P51954) 42% | |||||||||||||||||||
| 281 | NEK3a m | M | AF093416 | NIMA-related kinase NEK3. March 99 | STE | NEK | 511 | 336/458 (73%) NEK3 h | ||||||||||||||||||||
| 282 | NEK4 h | H | SUGEN | NEK4 h; NEK4a,b; HPK1 incyte (WO98/11234) | STE | NEK | 9q31-q32 (U) | 235 aa F19H6.1 ce 73%; 244 aa NEK1 m (P51954) 39% | ||||||||||||||||||||
| 283 | NEK5 h | H | SUGEN | NEK5 h | STE | NEK | NA | 256 aa NEK1 m (P51954) 37% | ||||||||||||||||||||
| 284 | NEK6 h | H | BAA83000 | NEK6 h | STE | NEK | 863 | NA | 207aa AF052296 dm 68%; F35G12.3b ce 44%; 292aa GAK h 40% | |||||||||||||||||||
| 285 | NRK2 h | H | NP 003148 | NRK2 h, STK2, MSTK2 m, NEK4 m (AF099067.1) | STE | NEK | 841 | 3p21.1 (gene list) | ||||||||||||||||||||
| 286 | MEKK3 h | H | AAB41729 | MEKK3 h | STE | STE11 | 626 | NA | ||||||||||||||||||||
| 287 | MEKK4a h | H | AAB68804 | MEKK4a h, MTK1, KIAA0213 Similar to TFIIi-associated transactivator factor | STE | STE11 | 1607 | 6 (OMIM) | ||||||||||||||||||||
| 288 | MEKK5 h | H | AAC50894 | MEKK5, ASK, MAPKKK5 h | STE | STE11 | 1374 | 6q22.33 (gene list) | ||||||||||||||||||||
| 289 | NIK h | H | CAA71306 | NIK h, NF-kappaB inducing kinas, MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1, NIK m (AF143094.1) | STE | STE11 | 947 | 17p21.1 (U) | ||||||||||||||||||||
| 290 | MEKK1 h | H | AAC97073 | MEKK1 h | STE | STE11 | 1495 | 5 (gene list) | ||||||||||||||||||||
| 291 | MEKK2 m | M | AAB03536 | MEKK2 m | STE | STE11 | 619 | M | 288aa MEK2 m 83%, 930bp 91% | |||||||||||||||||||
| 292 | MEKK6 | H | NP 004663 | MEKK6 h, ASK2 m apoptosis signal-regulating kinase 2 | STE | STE11 | 1011 | |||||||||||||||||||||
| 293 | YSK4 m | M | AAB61531 | YSK4 m | STE | STE11 | 65 | M | 65aa - MEKK3 h 46.2%; 40.7% | |||||||||||||||||||
| 294 | MST3 h | H | AAB82560 | MST3, STLK1 | STE | STE20-01 | 431 | 13q32.1-22 | MST3 h 100% STE20 h 89% | |||||||||||||||||||
| 295 | STE20 h | H | BAA20420 | YSK1, SOK | STE | STE20-01 | 426 | 2q34-37.2 (U) | ||||||||||||||||||||
| 296 | STLK2 | H | SUGEN | STLK2, (STE20-like kinase2) | STE | STE20-01 | Xq25-27.1 | |||||||||||||||||||||
| 297 | STLK3 | H | AAC72238 | STLK3, PASK r, SPAK m (AF099988) | STE | STE20-01 | 547 | |||||||||||||||||||||
| 298 | STLK4 | H | SUGEN | STLK4, (STE20-like kinase4) | STE | STE20-01 | ||||||||||||||||||||||
| 299 | STLK5 | H | SUGEN | STLK5, (STE20-like kinase5) | STE | STE20-01 | 17q23.2-24.2 | |||||||||||||||||||||
| 300 | STLK6 h | H | SUGEN | STLK6 h, (STE20-like kinase6) | STE | STE20-01 | 2q32.2-q33.3 | 243aa STLK5 h 50% | ||||||||||||||||||||
| 301 | STLK7 h | H | SUGEN | STLK7 h, (STE20-like kinase7) | STE | STE20-01 | NA | 102aa STLK3 h=SPAK h (AF099989) 86% (311bp 75%) | ||||||||||||||||||||
| 302 | PAK1 h | H | AAA65441 | PAK1, PAK-A m, alpha-PAK, p65-PAK, MUK2 r, p68PAK | STE | STE20-02 | 545 | 11q13-11q14 (gene list) | ||||||||||||||||||||
| 303 | PAK2 h | H | AAA65442 | PAK2, p65-PAK | STE | STE20-02 | 525 | NA | ||||||||||||||||||||
| 304 | PAK3 h | H | AAC36097 | PAK3, bPAK, PAK65, Gamma-PAK, p21-activated kinase3 | STE | STE20-02 | 544 | Xq21.3-q24 (OMIM) | hPAK65 h 95% | |||||||||||||||||||
| 305 | PAK4 h | H | SUGEN | PAK4 | STE | STE20-02 | ||||||||||||||||||||||
| 306 | PAK5 h | H | CAA09820 | PAK5 | STE | STE20-02 | 591 | |||||||||||||||||||||
| 307 | PAK6 h | H | CAA21067 | PAK6 Genomic clones | STE | STE20-02 | 138 | 136aa PAK5 81%, PAK4 h 74%, PAK3 h 53% | ||||||||||||||||||||
| 308 | ZC1 h | H | NP 004825 | ZC1, NIK m, HPK/GCK-like, KIAA0687 | STE | STE20-03 | 1165/1239 | |||||||||||||||||||||
| 309 | ZC2 h | H | BAA25477 | ZC2, KIAA0551 | STE | STE20-03 | 1333/1297 | |||||||||||||||||||||
| 310 | ZC3 h | H | SUGEN | ZC3 | STE | STE20-03 | 1326 | |||||||||||||||||||||
| 311 | ZC4 h | H | SUGEN | ZC4 | STE | STE20-03 | Xq22 | |||||||||||||||||||||
| 312 | HPK1 h | H | AAB97983 | HPK1 h | STE | STE20-04 | 833 | |||||||||||||||||||||
| 313 | BL44 h | H | AAA20968 | BL44, GCK, Rab8 interacting protein | STE | STE20-04 | 819 | 11q13 (OMIM) | ||||||||||||||||||||
| 314 | KHS1 h | H | AAB48435 | KHS1 h, kinase homologous to SPS1/STE20 | STE | STE20-04 | 846 | |||||||||||||||||||||
| 315 | KHS2 h | H | NP 003609 | KHS2 h, RAB8IPL1 (rab8 interacting protein-like 1) | STE | STE20-04 | 884 | |||||||||||||||||||||
| 316 | GEK2 h | H | NP 005981 | GEK2 h, GEK1 m, LOK, PLKK1 xl | STE | STE20-05 | 968 | NA 11/98 | ||||||||||||||||||||
| 317 | SLK h | H | BAA13195 | SLK h | STE | STE20-05 | 1152 | 16p13.3 | 253aa SLK h KIAA0204 h | |||||||||||||||||||
| 318 | SULU1 h | H | SUGEN | SULU1 | STE | STE20-06 | ||||||||||||||||||||||
| 319 | SULU2 h | H | BAA74904 | KIAA0881 h, TAO2 r, SULU2, protate-derived STE20-like kinase PSK | STE | STE20-06 | 1049 | 1050aa SULU3 h 70%; 921aa SULU1 64%, 970aa SULU ce 37% | ||||||||||||||||||||
| 320 | SULU3 r | H | AAC71014 | SULU3, TAO1 r | STE | STE20-06 | 1001 | 17p11.2 (gene list) | ||||||||||||||||||||
| 321 | MST1 h | H | AAB17262 | MST1, KRS-2 | STE | STE20-07 | 487 | 19q13.1-q13.2 (Ref Katoh) | ||||||||||||||||||||
| 322 | MST2 h | H | AAC50386 | MST2 h | STE | STE20-07 | 491 | 8q21.3-q23 (U) | ||||||||||||||||||||
| 323 | CDC7 h | H | AAC52080 | CDC7 h | STE | STE20-08 | 574 | 1q12-1p13.3 (U) | ||||||||||||||||||||
| 324 | MEK1 h | H | NP 002746 | MEK1, MKK1, MAPKK1 | STE | STE7 | 393 | 15q22.1-q22.33 (OMIM) | ||||||||||||||||||||
| 325 | MEK2 h | H | P36507 | MEK2 | STE | STE7 | 400 | 501bp MEK2 h 98% | ||||||||||||||||||||
| 326 | MEK5 h | H | AAA96146 | MEK5 h | STE | STE7 | 438 | NA | ||||||||||||||||||||
| 327 | MEK6 h | H | AAC50389 | MEK6, MKK6, SAPKK3 | STE | STE7 | 334 | 17q22 (U) | ||||||||||||||||||||
| 328 | MKK3 h | H | AAB40652 | MKK3, MEK3 | STE | STE7 | 347 | 17q11.2 (OMIM) | ||||||||||||||||||||
| 329 | MKK7a h | H | AAC26142 | MKK7a , SAPKK4, SAPKK5, JNKK2 | STE | STE7 | 419 | 19ptel (U) | ||||||||||||||||||||
| 330 | MPK3b h | H | P46734 | MKK3, MPK3, MAPKK3b, SAPKK2 | STE | STE7 | 347 | NA | 334aa MPK6 h 80%; MPK4 h 49% | |||||||||||||||||||
| 331 | MPK4 h | H | AAC41719 | MPK4, MKK4, SEK1, MEK4, JNKK, SAPKK1 | STE | STE7 | 399 | 17p11.2 (gene list) | ||||||||||||||||||||
| 332 | BLK h | H | AAB33265 | B lymphoid Tyr kin | TK | CTK-01 | 505 | 8p23-8p22 (gene list) | ||||||||||||||||||||
| 333 | FGR h | H | AAA52451 | FGR h | TK | CTK-01 | 529 | 1p36.1-36.2 | ||||||||||||||||||||
| 334 | FYN h | H | NP 002028 | FYN, Slk, Syn | TK | CTK-01 | 537 | 6q21 (OMIM) | ||||||||||||||||||||
| 335 | HCK h | H | P08631 | HCK, Bmk | TK | CTK-01 | 526 | 20q11-20q12 (gene list) | ||||||||||||||||||||
| 336 | LCK h | H | P06239 | LCK, Tkl | TK | CTK-01 | 509 | 1p35-1p34.3 (gene list) | ||||||||||||||||||||
| 337 | LYN h | H | NP 002341 | LYN h | TK | CTK-01 | 513 | 8q11-12 (ref, corey) | ||||||||||||||||||||
| 338 | SRC h | H | P12931 | SRC h | TK | CTK-01 | 543 | 20q11.2-q13 (MIM) | ||||||||||||||||||||
| 339 | YES h | H | AAA35735 | YES h | TK | CTK-01 | 543 | 18p11.3 (OMIM) (pseudo CHR 22) | ||||||||||||||||||||
| 340 | FERpsu h | H | psu | FER pseudogene, SuCTK04 | TK | CTK-01p | pseudo | 73aa FER m 72% | ||||||||||||||||||||
| 341 | FYNpsu h | M | psu | FYN pseudo | TK | CTK-01p | M | 184aa - FYN h 62.7%; 62.8%; | ||||||||||||||||||||
| 342 | BRK h | H | CAA55295 | BRK, Cck3, PTK6 | TK | CTK-02 | 451 | NA | ||||||||||||||||||||
| 343 | FRK h | H | NP 002022 | FRK, MKK3, Tk1, Rak, IYK m, BSK m, GTK r | TK | CTK-02 | 505 | NA | ||||||||||||||||||||
| 344 | SAD h | H | SUGEN | SAD h | TK | CTK-02 | NA | |||||||||||||||||||||
| 345 | SRM m | M | Q62270 | SRM | TK | CTK-02 | 496 | |||||||||||||||||||||
| 346 | TXK h | H | AAA74557 | TXK, Rlk | TK | CTK-03 | 527 | 4p12 (gene list) | 257aa TXK h 100% TXK m 88%; TEC m 68% | |||||||||||||||||||
| 347 | BMX h | H | CAA58169 | Bmx, MKK2 | TK | CTK-03 | 675 | Xp22.2 (gene list) | ||||||||||||||||||||
| 348 | BTK h | H | Q06187 | BTK, Atk, Bpk, Bruton agammaglobulinemia | TK | CTK-03 | 659 | Xq21.33-q22 (gene list) | ||||||||||||||||||||
| 349 | ITK h | H | NP 005537 | ITK, Lyk, Tsk, Emt, IL2-inducible T-cell kinase | TK | CTK-03 | 620 | 5q31-5q32 | ||||||||||||||||||||
| 350 | TEC h | H | NP 003206 | TEC h | TK | CTK-03 | 631 | 4p12 (gene list) | ||||||||||||||||||||
| 351 | CSK h | H | P41240 | CSK | TK | CTK-04 | 450 | 15q23-q25 (LocusLink) | ||||||||||||||||||||
| 352 | CTK h | H | P42679 | CTK, Mkk1, MATK, Hyl, Lsk, Ntk | TK | CTK-04 | 505 | 19p13.3 (gene list) | ||||||||||||||||||||
| 353 | ABL h | H | P00519 | ABL h | TK | CTK-05 | 1130 | |||||||||||||||||||||
| 354 | ARG h | H | NP 005149 | ARG h | TK | CTK-05 | 1182 | 1q24-q25 (OMIM) | ||||||||||||||||||||
| 355 | SYK h | H | P43405 | SYK, spleen tyr kinase | TK | CTK-06 | 635 | 9q22 (gene list) | ||||||||||||||||||||
| 356 | ZAP70 h | H | P43403 | ZAP70 h | TK | CTK-06 | 619 | 2q11-2q13 (gene list) | ||||||||||||||||||||
| 357 | FER h | H | NP 005237 | FER, Flk | TK | CTK-07 | 822 | 5q12-21 (gene list) | ||||||||||||||||||||
| 358 | FES h | H | P07332 | FES, FPS | TK | CTK-07 | 822 | 15q26.1 (OMIM) | ||||||||||||||||||||
| 359 | FAK h | H | Q05397 | PTK2 | TK | CTK-08 | 1052 | 8q24 (OMIM) | ||||||||||||||||||||
| 360 | PYK2 h | H | NP 004094 | FAK2, CAKb, RAFTK, PTK2B | TK | CTK-08 | 1009 | 8p21.1 (gene list) | ||||||||||||||||||||
| 361 | JAK1 h | H | NP 002218 | JAK1 h | TK | CTK-09 | 1142 | 1p32.3-1p31.3 (gene list) | ||||||||||||||||||||
| 362 | JAK2 h | H | NP 004963 | JAK2 h | TK | CTK-09 | 1132 | 9p24 (gene list) | ||||||||||||||||||||
| 363 | JAK3 h | H | NP 000206 | JAK3 h | TK | CTK-09 | 1124 | 19p13.1 (gene list) | ||||||||||||||||||||
| 364 | TYK2 h | H | NP 003322 | TYK2 h | TK | CTK-09 | 1187 | 19p13.2 (gene list) | ||||||||||||||||||||
| 365 | ACK h | H | NP 005772 | ACK, Pyk1 | TK | CTK-10 | 1091 | |||||||||||||||||||||
| 366 | TNK1 h | H | AAC50427 | TNK1 h, ACK2 | TK | CTK-10 | 666 | NA | ||||||||||||||||||||
| 367 | EGFR h | H | NP 005219 | EGFR, ErbB | TK | RTK-01 | 1210 | 7p12.3-p12.1 (OMIM) | ||||||||||||||||||||
| 368 | HER2 h | H | NP 004439 | HER2, ErbB2 | TK | RTK-01 | 1255 | 17q21.2 (OMIM) | ||||||||||||||||||||
| 369 | HER3 h | H | NP 001973 | HER3, ErbB3 | TK | RTK-01 | 1342 | 12q13 (Entrez) | ||||||||||||||||||||
| 370 | HER4 h | H | NP 005226 | HER4, ErbB4 | TK | RTK-01 | 1308 | 2q33.3-q34 (OMIM) | ||||||||||||||||||||
| 371 | IGF1R h | H | NP 000866 | IGF1R h | TK | RTK-02 | 1367 | 15q25-q26 (OMIM) | ||||||||||||||||||||
| 372 | INSR h | H | P06213 | INSR h | TK | RTK-02 | 1382 | 19p13.2 (OMIM) | ||||||||||||||||||||
| 373 | IRR h | H | P14616 | IRR h | TK | RTK-02 | 1268 | Chr.1 (OMIM) | ||||||||||||||||||||
| 374 | CSFR h | H | P07333 | CSFR h | TK | RTK-03 | 972 | 5q33.2-q33.3 (U) | ||||||||||||||||||||
| 375 | KIT h | H | NP 000213 | KIT h | TK | RTK-03 | 976 | 4q12 (U) | ||||||||||||||||||||
| 376 | PDGFRa h | H | NP 006197 | PDGFRa h | TK | RTK-03 | 1089 | Chr.11, D11S1357-D11S1765 | ||||||||||||||||||||
| 377 | PDGFRb h | H | NP 002600 | PDGFRb h | TK | RTK-03 | 1106 | 5q31-q32 (U) | ||||||||||||||||||||
| 378 | FLK2 h | H | NP 004110 | FLK2, Flt3, STK1 | TK | RTK-04 | 993 | M | ||||||||||||||||||||
| 379 | FLT1 h | H | NP 002010 | FLT1 h | TK | RTK-04 | 1338 | 13q12 (gene list) | ||||||||||||||||||||
| 380 | FLT4 h | H | P35916 | FLT4 h | TK | RTK-04 | 1298 | 5q34-5q35 (gene list) | ||||||||||||||||||||
| 381 | KDR h | H | AAB88005 | KDR, FLK1, NYK | TK | RTK-04 | 1356 | 4q12 (gene list) | ||||||||||||||||||||
| 382 | FGFR1 h | H | P11362 | FGFR1, FLG, CEK1 | TK | RTK-05 | 822 | 8p11.2-8p11.1 (gene list) | ||||||||||||||||||||
| 383 | FGFR2 h | H | NP 000132 | FGFR2, BEK, KSAM, KSAMI, Cek3 | TK | RTK-05 | 821 | 10q25.3-10q26 (gene list) | ||||||||||||||||||||
| 384 | FGFR3 h | H | NP 000133 | FGFR3, CEK2 | TK | RTK-05 | 806 | 4p16.3 (gene list) | ||||||||||||||||||||
| 385 | FGFR4 h | H | NP 002002 | FGFR4 h | TK | RTK-05 | 802 | 5q35.1-5qter (gene list) | ||||||||||||||||||||
| 386 | FGFR3pse m | M | psu | FGFR3pseudo m | TK | RTK-05p | M | 266aa - FGFR3 h 66%; | ||||||||||||||||||||
| 387 | CCK4 h | H | AAA87565 | CCK4, KLG | TK | RTK-06 | 1070 | 6p21.1-p12.2 | ||||||||||||||||||||
| 388 | MET h | H | NP 000236 | MET h | TK | RTK-07 | 1408 | 7q31 (OMIM) | ||||||||||||||||||||
| 389 | RON h | H | NP 002438 | RON, MST1R, CCK1, MDK3 | TK | RTK-07 | 1400 | 3p21.3 (gene list) | ||||||||||||||||||||
| 390 | TRKA h | H | NP 002520 | NTRK1 | TK | RTK-08 | 796 | 1q21-1q22 (gene list) | ||||||||||||||||||||
| 391 | TRKB h | H | NP 006171 | TRKB | TK | RTK-08 | 822 | 9q22.1 (gene list) | ||||||||||||||||||||
| 392 | TRKC h | H | NP 002521 | TRKC h | TK | RTK-08 | 825 | 15q24-15q25 (gene list) | ||||||||||||||||||||
| 393 | MER h | H | NP 006334 | MER, TYRO12, c-ryk, EYK?? | TK | RTK-09 | 999 | 2q12 (U) | ||||||||||||||||||||
| 394 | AXL h | H | NP 001690 | AXL, ARK, UFO | TK | RTK-09 | 885 | 19q13.1 (gene list) | ||||||||||||||||||||
| 395 | TYRO3 h | H | NP 006284 | TYRO3, Sky, Rse, Tif, Brt, DTK | TK | RTK-09 | 882 | 15q15.1-15q21.1 (gene list) | ||||||||||||||||||||
| 396 | ZPK h | H | AAC41766 | ZPK h | TK | RTK-09 | 600 | L08961 = c-mer | ||||||||||||||||||||
| 397 | Tyro3psu h | H | psu | Tyro3psu h | TK | RTK-09p | NA | 274aa Tyro3 h 86% | ||||||||||||||||||||
| 398 | TEK h | H | NP 000450 | TEK, TIE2, HPK-6 | TK | RTK-10 | 1124 | 9p21 (gene list) | ||||||||||||||||||||
| 399 | TIE h | H | NP 005415 | TIE h | TK | RTK-10 | 1138 | 1p34-p33 (OMIM) | ||||||||||||||||||||
| 400 | EphA1 h | H | NP 005223 | EphA1, Eph, Esk | TK | RTK-11 | 984 | 7q32-7q36 (gene list) | ||||||||||||||||||||
| 401 | EphA2 h | H | NP 004422 | EphA2, Eck, Myk2, Sek2 | TK | RTK-11 | 976 | 1p36.1 (gene list) | ||||||||||||||||||||
| 402 | EphA3 h | H | NP 005224 | EphA3, Cek4, Mek4, Hek, Tyro4, Hek4 | TK | RTK-11 | 983 | 3p11.2 (gene list) | ||||||||||||||||||||
| 403 | EphA4 h | H | NP 004429 | EphA4, Sek, Sek1, Cek8, Hek8, Tyro1 | TK | RTK-11 | 986 | NA | ||||||||||||||||||||
| 404 | EphA5 h | H | P54756 | EphA5, Ehk1, Bsk, Cek7, Hek7, Rek7 | TK | RTK-11 | 1037 | NA | ||||||||||||||||||||
| 405 | EphA6 m | M | Q62413 | EphA6, Ehk2,Hek12 | TK | RTK-11 | 1035 m | M | 314aa - EphA7 h 71.0% | |||||||||||||||||||
| 406 | EphA7 h | H | NP 004431 | EphA7, Mdk1, Hek11, Ehk3, Ebk, Cek11 | TK | RTK-11 | 998 | 6q14-15 (U) | ||||||||||||||||||||
| 407 | EphA8 m | M | O09127 | EphA8, Eek, Hek3 | TK | RTK-11 | 1004 m | 1 (gene list) | 260aa EphA7 h 74.1% | |||||||||||||||||||
| 408 | EphB1 h | H | NP 004432 | EphB1, Elk, Cek6, Net, Hek6 | TK | RTK-11 | 984 | 3q21-3q23 (gene list) | ||||||||||||||||||||
| 409 | EphB2 h | H | NP 004433 | EphB2, Cek5, Nuk, Erk, Qek5, Tyro5, Sek3, Hek5, Drt | TK | RTK-11 | 987 | 1p36.1 (gene list) | ||||||||||||||||||||
| 410 | EphB3 h | H | NP 004434 | EphB3, Cek10, Hek2, Mdk5, Tyro6, Sek4 | TK | RTK-11 | 998 | 3q21-3qter (gene list) | ||||||||||||||||||||
| 411 | EphB4 h | H | NP 004435 | EphB4, Htk, Myk1, Tyro11, Mdk2 | TK | RTK-11 | 987 | 7 (gene list) | ||||||||||||||||||||
| 412 | EphB5 c | C | Q07497 | EphB5, Cek9, Hek9 | TK | RTK-11 | 1002 | C | ||||||||||||||||||||
| 413 | EphB6 h | H | NP 004436 | EphB6, Mep | TK | RTK-11 | 1006 | 7q33-7q35 (gene list) | ||||||||||||||||||||
| 414 | RYK h | H | P34925 | RYK, Vik, Nykr | TK | RTK-12 | 604 | 3q22 (gene list) | ||||||||||||||||||||
| 415 | DDR h | H | Q08345 | DDR, MCK10, Cak, Nep, MPK-6 | TK | RTK-13 | 913 | 6p21.3 (OMIM) or 6q16 (LocusLink) | ||||||||||||||||||||
| 416 | RTK40 | R | AF016247 | RTK40 homolog, tyro10 | TK | RTK-13 | 168 | 137/155 (88%) TYRO10 m; 660/726 (90%) | ||||||||||||||||||||
| 417 | TYRO10 h | H | NP 006173 | TYRO10, DDR2, Tkt, Cck2 | TK | RTK-13 | 855 | 1q21-1q23 (gene list) | ||||||||||||||||||||
| 418 | ROS h | H | NP 002935 | ROS h | TK | RTK-14 | 2347 | 6q22 (U) | ||||||||||||||||||||
| 419 | RET h | H | P07949 | RET h | TK | RTK-15 | 1114 | 10q11.2 (OMIM) | ||||||||||||||||||||
| 420 | ALK h | H | NP 004295 | Anaplastic lymphoma kinase | TK | RTK-16 | 1620 | 2p23 (gene list) | ||||||||||||||||||||
| 421 | LTK h | H | P29376 | LTK h | TK | RTK-16 | 864 | 15q15.1-15q15.2 (gene list) | ||||||||||||||||||||
| 422 | ROR1 h | H | NP 005003 | ROR1 h, neurotrophic tyrosine kinase, receptor-related 1 | TK | RTK-17 | 937 | |||||||||||||||||||||
| 423 | ROR2 h | H | NP 004551 | ROR2 h, NTRKR2, neurotrophic tyrosine kinase, receptor-related 2 | TK | RTK-17 | 943 | 9q21.3 (U) | ||||||||||||||||||||
| 424 | MUSK h | H | NP 005583 | MUSK, NSK2, NP-1, Mdk4, Torpedo, MLK1 | TK | RTK-18 | 869 | 9q31.3-9q32 (gene list) | ||||||||||||||||||||
| 425 | LMR1 h | H | NP 004911 | LMR1 h, KIAA0641, apoptosis-associated tyrosine kinase | TK | RTK-19 | 1207+ | NA | ||||||||||||||||||||
| 426 | LMR2 h | H | BAA83031 | LMR2 h, KIAA1079 | TK | RTK-19 | 1454+ | 7q21.3-22.1 | ||||||||||||||||||||
| 427 | LMR3 h | H | LMR3 h | TK | RTK-19 | NA | ||||||||||||||||||||||
| 428 | RTK106 h | H | SuRTK106 h | TK | RTK-20 | 12p12.3 (Shirley) | ||||||||||||||||||||||